The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
Open accessAbstract
Life expectancy in patients with schizophrenia is reduced by 20 years for men and 15 years for women compared to the general population. About 60% of the excess mortality is due to physical illnesses, with cardiovascular disease being dominant. CHANGE was a randomized, parallel‐group, superiority, multi‐centre trial with blinded outcome assessment, testing the efficacy of an intervention aimed to improve cardiovascular risk profile and hereby potentially reduce mortality. A total of 428 patients with schizophrenia spectrum disorders and abdominal obesity were recruited and centrally randomized 1:1:1 to 12 months of lifestyle coaching plus care coordination plus treatment as usual (N=138), or care coordination plus treatment as usual (N=142), or treatment as usual alone (N=148). The primary outcome was 10‐year risk of cardiovascular disease assessed post‐treatment and standardized to age 60. At follow‐up, the mean 10‐year risk of cardiovascular disease was 8.4 ± 6.7% in the group receiving lifestyle coaching, 8.5 ± 7.5% in the care coordination group, and 8.0 ± 6.5% in the treatment as usual group (p=0.41). We found no intervention effects for any secondary or exploratory outcomes, including cardiorespiratory fitness, physical activity, weight, diet and smoking. In conclusion, the CHANGE trial did not support superiority of individual lifestyle coaching or care coordination compared to treatment as usual in reducing cardiovascular risk in patients with schizophrenia spectrum disorders and abdominal obesity.
AI snapshot
Written from the paper’s full text.
TL;DR
The CHANGE trial found that 12 months of lifestyle coaching plus care coordination plus treatment as usual, or care coordination plus treatment as usual, was not superior to treatment as usual alone in reducing 10-year cardiovascular disease risk in adults with schizophrenia spectrum disorders and abdominal obesity. No intervention effects were found for secondary or exploratory outcomes, including cardiorespiratory fitness, weight, diet, and smoking.
Key findings
- Among 428 randomized participants, mean age-standardized 10-year cardiovascular disease risk at follow-up was 8.4 ± 6.7% with lifestyle coaching, 8.5 ± 7.5% with care coordination, and 8.0 ± 6.5% with treatment as usual (p = 0.41).
- There were no differences for the key secondary outcome, cardiorespiratory fitness: 18.1 ± 5.5, 18.0 ± 6.8, and 18.2 ± 6.7 ml O₂/min/kg, respectively (p = 0.54).
- No significant differences were found for exploratory outcomes, including weight (103.1 ± 23.8 kg, 103.7 ± 21.2 kg, and 102.9 ± 21.7 kg; p = 0.18) and daily smoking (49.0%, 49.0%, and 50.0%).
- Psychiatric hospitalizations were 18.8% in the CHANGE group, 33.8% in the care coordination group, and 24.3% in treatment as usual; the difference between care coordination and CHANGE was statistically significant (p = 0.004).
Methods
- Randomized, parallel-group, superiority, multi-centre trial with blinded outcome assessment; 428 adults with schizophrenia spectrum disorders and abdominal obesity were centrally randomized 1:1:1 to lifestyle coaching plus care coordination plus treatment as usual (N = 138), care coordination plus treatment as usual (N = 142), or treatment as usual alone (N = 148).
- Participants were recruited from catchment areas in Aarhus and Copenhagen, Denmark; eligibility included ICD-10 schizophrenia, schizoaffective disorder, or persistent delusional disorder and waist circumference above 88 cm for women and 102 cm for men.
- Primary outcome was 10-year risk of cardiovascular disease assessed post-treatment and standardized to age 60 using the Copenhagen risk score; analysis was intention-to-treat with multiple imputation and ANCOVA, with Bonferroni-adjusted alpha of 0.0167 for the primary outcome.
Limitations
- The paper states that recruitment stopped at 428 participants instead of the planned 450, so underpowering and type II error cannot be excluded, although the authors report 87.2% power for the primary outcome.
- The paper states that the surrogate cardiovascular risk score lacks validation in schizophrenia, that lifestyle measures were not validated in this population, and that self-report may introduce recall and social desirability bias.
- The paper states that generalizability of care coordination may be limited to countries with similar healthcare systems; it also notes that patients and intervention staff were not blinded, while outcome assessors, statisticians, and investigators were blinded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 30 cited sources checked · 0 supported · 0 flagged
- Findingown data
The means for cardiorespiratory fitness were 18.1±5.5 ml O2/min/Kg in the CHANGE group, 18.0±6.8 ml O2/min/Kg in the care coordination group, and 18.2±6.7 ml O2/min/Kg in the treatment as usual group (F=0.86, p=0.54).
“The means for cardiorespiratory fitness, our key secondary outcome, were 18.1 6 5.5 ml O 2 / min/Kg in the CHANGE group, 18.0 6 6.8 ml O 2 /min/Kg in the care coordination group, and 18.2 6 6.7 ml O 2 /min/Kg in the treatment as usual group (F 2,428 50.86, p50.54).”
Quote in the paperNot a substantial claim - Findingown data
After removing outliers, the mean age-standardized 10-year risk was 7.9±5.2% in the CHANGE group, 7.6±4.9% in the care coordination group and 7.1±4.1% in the treatment as usual group (p=0.18).
“After removing outliers, we found that it was 7.9 6 5.2% in the CHANGE group, 7.6 6 4.9% in the care coordination group and 7.1 6 4.1% in the treatment as usual group (p50.18).”
Quote in the paperSubstantial claim - Findingown data
The mean age-standardized 10-year risk of cardiovascular disease at follow-up was 8.4±6.7% in the lifestyle coaching group, 8.5±7.5% in the care coordination group, and 8.0±6.5% in the treatment as usual group (p=0.41).
“At follow-up, the mean 10-year risk of cardiovascular disease was 8.4 6 6.7% in the group receiving lifestyle coaching, 8.5 6 7.5% in the care coordination group, and 8.0 6 6.5% in the treatment as usual group (p50.41).”
Quote in the paperSubstantial claim - Findingown data
The CHANGE trial provides evidence that a manual-based individual lifestyle coaching intervention does not reduce the 10-year risk of cardiovascular disease, compared with treatment as usual, in patients with schizophrenia spectrum disorders and abdominal obesity.
“In conclusion, the CHANGE trial provides evidence that a manual-based individual lifestyle coaching intervention does not reduce the 10-year risk of cardiovascular disease, compared with treatment as usual, in patients with schizophrenia spectrum disorders and abdominal obesity.”
Quote in the paperSubstantial claim - Findingown data
Somatic hospitalizations amounted to 12.3% in the CHANGE group, 17.6% in the care coordination group and 16.2% in the control group (p=0.40).
“Somatic hospitalizations amounted to 12.3% in the CHANGE group, 17.6% in the care coordination group and 16.2% in the control group (p50.40).”
Quote in the paperNot a substantial claim
- Findingown data
When analyzing complete cases, the mean age-standardized 10-year risk of cardiovascular disease was 8.5±7.0% in the CHANGE group, 8.6±7.8 in the care coordination group and 7.4±5.3% in the treatment as usual group (p=0.46).
“When analyzing complete cases, we found that the mean agestandardized 10-year risk of cardiovascular disease was 8.5 6 7.0% in the CHANGE group, 8.6 6 7.8 in the care coordination group and 7.4 6 5.3% in the treatment as usual group (p50.46).”
Quote in the paperSubstantial claim - Findingown data
We found no intervention effects for any secondary or exploratory outcomes, including cardiorespiratory fitness, physical activity, weight, diet and smoking.
“We found no intervention effects for any secondary or exploratory outcomes, including cardiorespiratory fitness, physical activity, weight, diet and smoking.”
Quote in the paperSubstantial claim - Findingown data
There were no differences between the three groups for any of the secondary outcomes.
“There were no differences between the three groups for any of the secondary outcomes.”
Quote in the paperSubstantial claim - Findingown data
The analyses revealed no significant differences between the three groups on any exploratory outcomes.
“The analyses revealed no significant differences between the three groups on any exploratory outcomes (Table 3).”
Quote in the paperSubstantial claim - Findingown data
For weight, the means were 103.1±23.8 Kg in the CHANGE group, 103.7±21.2 Kg in the care coordination group, and 102.9±21.7 Kg in the treatment as usual group (F=1.91, p=0.18).
“For weight, the means were 103.1 6 23.8 Kg in the CHANGE group, 103.7 6 21.2 Kg in the care coordination group, and 102.9 6 21.7 Kg in the treatment as usual group (F 2,428 51.91, p50.18).”
Quote in the paperNot a substantial claim - Findingcitation
Few participants had baseline values of lipids or blood pressure indicating a need for change in medication, according to current guidelines for cardiovascular prevention.
“Few of our participants had baseline values of lipids or blood pressure indicating a need for change in medication, according to the current guidelines for cardiovascular prevention 42”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42]
Not checked in the free run.
- Findingown data
After removing CHANGE participants who had less than half of the intended 42 sessions, the mean risk was 8.6±7.7% in the CHANGE group, 8.6±7.8% in the care coordination group and 7.4±5.3% in the treatment as usual group (p=0.65).
“After removing CHANGE participants who had less than half of the intended 42 sessions, we found that the mean risk was 8.6 6 7.7% in the CHANGE group, 8.6 6 7.8% in the care coordination group and 7.4 6 5.3% in the treatment as usual group (p50.65).”
Quote in the paperNot a substantial claim - Findingown data
Only 60.0% of patients randomized to the CHANGE group attended at least half of the intended weekly meetings.
“In spite of a high retention proportion (86.0%), the perprotocol analysis showed that only 60.0% of patients randomized to the CHANGE group attended at least half of the intended weekly meetings”
Quote in the paperSubstantial claim - Findingown data
Only two participants had haemoglobin A1c values above the cut-off for diabetes without having been diagnosed and treated beforehand.
“only two had haemoglobin A1c values above the cut-off for diabetes without having being diagnosed and treated beforehand.”
Quote in the paperSubstantial claim - Findingown data
There were no indications of significant reductions even in the separate modifiable risk factors.
“This was not an issue in the CHANGE trial, as there were no indications of significant reductions even in the separate modifiable risk factors.”
Quote in the paperSubstantial claim - Findingown data
The retention proportion was 86.0%.
“In spite of a high retention proportion (86.0%), the perprotocol analysis showed that only 60.0% of patients randomized to the CHANGE group attended at least half of the intended weekly meetings”
Quote in the paperNot a substantial claim - Premisecitation
One U.S. study found a significant effect of care coordination on a composite cardiovascular risk score in patients with severe mental illness.
“One U.S. study had explored the impact of care coordination in patients with severe mental illness, using a composite cardiovascular risk score, finding a significant effect 41 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
Not checked in the free run.
- Interpretationown data
The CHANGE trial did not support superiority of individual lifestyle coaching or care coordination compared to treatment as usual in reducing cardiovascular risk in patients with schizophrenia spectrum disorders and abdominal obesity.
“In conclusion, the CHANGE trial did not support superiority of individual lifestyle coaching or care coordination compared to treatment as usual in reducing cardiovascular risk in patients with schizophrenia spectrum”
- Also stated in: § DISCUSSION · hedged
“However, the findings of this trial suggest that neither the CHANGE intervention nor care coordination were superior to standard treatment in reducing the 10-year risk of cardiovascular disease.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · hedged
- Study design and conductown data
There was no difference in dropout rates among the three groups (p=0.68).
“There was no difference in the dropout rates among the three groups (p50.68).”
Quote in the paperNot a substantial claim - Premisecitation
Medication with antipsychotic drugs can be considered partly modifiable, as reducing doses or switching prescriptions only leads to moderate improvement of metabolic risk factors.
“Of these risk factors, medication with antipsychotic drugs can be considered partly modifiable, as reducing doses or switching prescriptions only leads to moderate improvement of metabolic risk factors 10,11 .”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
The correlation between weight loss and mortality remains questionable.
“weight reduction or weight gain prevention is the most used outcome, but the correlation between weight loss and mortality remains questionable 15 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] source
Not checked in the free run.
- Premisecitation
Research published after the initiation of this trial has questioned the generalizability of cardiovascular risk scores to people with severe mental illness.
“In fact, research published after the initiation of this trial has questioned the generalizability of cardiovascular risk scores to people with severe mental illness 58 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] source
Not checked in the free run.
- Rests on an assumption: Currently there is no gold standard for surrogate outcomes in trials aiming to improve cardiovascular health.
- Study design and conductown data
The trial still has a power of 87.2% regarding the primary outcome.
“and we still have a power of 87.2% regarding our primary outcome, which seems an acceptable one compared to most trials.”
Quote in the paperSubstantial claim - Interpretationreasoning
The generalizability of results of care coordination might be limited to countries with similar health care systems.
“Thus, the generalizability of results of care coordination might be limited to countries with similar health care systems.”
Quote in the paperSubstantial claim - Study design and conductown data
The authors cannot exclude a risk of being underpowered, increasing the risk for type II errors.
“we cannot exclude a risk of being underpowered, increasing the risk for type II errors.”
Quote in the paperSubstantial claim - Interpretationreasoning
The heterogeneity of the intervention might have limited the possibility to show an effect on single metabolic outcomes, thus reducing power.
“This might have limited our possibility to show an effect on single metabolic outcomes, thus reducing our power.”
Quote in the paperSubstantial claim - Study design and conductcitation
The surrogate measure lacks validation in a population with schizophrenia.
“A weakness, though, is the lack of validation of the surrogate measure in a population with schizophrenia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] source
Not checked in the free run.
- Rests on an assumption: Currently there is no gold standard for surrogate outcomes in trials aiming to improve cardiovascular health.
- Study design and conductnone given
The design had blinded outcome assessments, data management and data analysis.
“First, the design had central randomization; blinded outcome assessments, data management and data analysis; and independent funding.”
Quote in the paperNot a substantial claim - Study design and conductnone given
The intervention was heterogeneous, as every patient was free to choose the focus area for the intervention in dialogue with the coach.
“Our intervention was heterogeneous, as every patient was free to choose the focus area for the intervention in dialogue with the coach.”
Quote in the paperSubstantial claim - Interpretationown data
Offering a higher frequency of sessions or a lower caseload would doubtfully have led to different results.
“indicating that offering a higher frequency of sessions or a lower caseload would doubtfully have led to different results.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
The lack of effect on individual risk behaviours should be interpreted with caution, due to insufficient power.
“The lack of effect on individual risk behaviours should be interpreted with caution, due to insufficient power.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The authors find it unlikely that including 22 further participants would have changed their results substantially.
“However, we find it unlikely that including 22 further participants would have changed our results substantially”
Quote in the paperSubstantial claim - Study design and conductown data
The authors did not succeed in recruiting the planned number of participants (recruited 428, expected 450).
“As we did not succeed in recruiting the planned number of participants (we recruited 428 patients, while 450 were expected)”
Quote in the paperSubstantial claim
- May combine two claims. 23
- Classified as probably not a substantial claim. 39
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataPsychiatric hospitalizations amounted to 18.8% in the CHANGE group, 33.8% in the care coordination group and 24.3% in the treatment as usual group; the difference between the care coordination and the CHANGE group was statistically significant (p=0.004).
“Psychiatric hospitalizations amounted to 18.8% in the CHANGE group, 33.8% in the care coordination group and 24.3% in the treatment as usual group; the difference between the care coordination and the CHANGE group was statistically significant (p50.004).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFive patients died during the trial.
“Five patients died during the trial.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA total of 428 patients with schizophrenia spectrum disorders and abdominal obesity were recruited and centrally randomized 1:1:1 to 12 months of lifestyle coaching plus care coordination plus treatment as usual, or care coordination plus treatment as usual, or treatment as usual alone.
“A total of 428 patients with schizophrenia spectrum disorders and abdominal obesity were recruited and centrally randomized 1:1:1 to 12 months of lifestyle coaching plus care coordination plus treatment as usual (N5138), or care coordination plus treatment as usual (N5142), or treatment as usual alone (N5148).”
- Also stated in: § RESULTS · plain
“Between December 2012 and May 2014, 428 participants were assigned to receive the CHANGE intervention (N5138), or care coordination plus treatment as usual (N5142), or treatment as usual alone (N5148).”
Quote in the paperSubstantial claim- Also stated in: § RESULTS · plain
May combine two claims.
Findingown dataThe proportion of daily smokers was 49.0% in the CHANGE group, 49.0% in the care coordination group, and 50.0% in the treatment as usual group (CHANGE vs TAU p=0.65; care coordination vs TAU p=0.79).
“The proportion of daily smokers was 49.0% in the CHANGE group, 49.0% in the care coordination group, and 50.0% in the treatment as usual group (CHANGE group vs. treatment as usual group: p50.65; care coordination group vs. treatment as usual group: p50.79).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataIn the CHANGE group, the mean number of personal meetings was 24.6±14.5; 60.0% attended 21 or more of the intended 42 personal meetings; 97.8% had at least one personal meeting with their coach.
“In the CHANGE group, the mean number of personal meetings was 24.6 6 14.5; 60.0% of the participants attended 21 or more of the intended 42 personal meetings; 97.8% had at least one personal meeting with their coach.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFollow-ups after the intervention has ended are important, as the effect of lifestyle modification tends to vanish, and an intentional weight loss may be followed by an unhealthy weight gain in the majority of participants in behavioural trials.
“Equally important are follow-ups after the intervention has ended, as the effect of lifestyle modification tends to vanish, and an intentional weight loss may be followed by an unhealthy weight gain in the majority of participants in behavioural trials 19 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
May combine two claims.
Study design and conductown dataCHANGE was a randomized, parallel-group, superiority, multi-centre trial with blinded outcome assessment.
“CHANGE was a randomized, parallel-group, superiority, multi-centre trial with blinded outcome assessment”
- Also stated in: § Study design and participants · plain
“CHANGE was an investigator-initiated, independently funded, randomized, parallel-group, superiority, multi-centre trial with blinded outcome assessment.”
Quote in the paperSubstantial claim- Also stated in: § Study design and participants · plain
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
PremisecitationInterventions with long-term follow-up are warranted, since there are no reasons to believe that changes in metabolic risk factors occur faster in patients with severe mental disorders than the general population.
“Interventions with long-term follow-up are also warranted, since there are no reasons to believe that changes in metabolic risk factors occur faster in patients with severe mental disorders than the general population 18 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe trial protocol was published in 2015 with no changes made to the original version.
“The trial protocol was published in 2015 with no changes made to the original version 21 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe trial had to stop before the planned 450 participants due to lack of referrals.
“According to the protocol, we ought to include 450 participants, but had to stop before, due to lack of referrals.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAbout 60% of excess mortality in schizophrenia is due to physical illnesses, with cardiovascular disease being dominant.
“About 60% of the excess mortality is due to physical illnesses, with cardiovascular disease being dominant.”
- Also stated in: § Abstract · plain
“About 60% of the premature mortality in schizophrenia is due to physical diseases 3 , with cardiovascular disease explaining the majority 4 .”
Quote in the paperNot a substantial claim0 of 2 sources checked- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S2 (checkable).
PremisecitationSince the pathogenesis of cardiovascular disease is multifactorial, strategies to reduce multiple, concurrent risk behaviours are needed.
“Moreover, since the pathogenesis of cardiovascular disease is multifactorial, strategies to reduce multiple, concurrent risk behaviours are needed 17 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationComposite surrogate outcomes assessing the risk of cardiovascular disease have been proposed.
“To overcome this, composite surrogate outcomes assessing the risk of cardiovascular disease have been proposed 16 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe authors' negative results might be explained by better access to primary care in Denmark.
“Our negative results might be explained by better access to primary care in Denmark.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataFor the primary outcome, p values were Bonferroni-adjusted (alpha level 0.05/3=0.0167).
“For the primary outcome, the p values were Bonferroni-adjusted (alpha level50.05/350.0167).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningInsufficient treatment of somatic comorbidity and unhealthy lifestyle are potentially fully modifiable and, if properly targeted, life expectancy for patients with schizophrenia might improve.
“Insufficient treatment of somatic comorbidity and unhealthy lifestyle are potentially fully modifiable and, if they are properly targeted, life expectancy for patients with schizophrenia might improve.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe primary outcome used the Copenhagen risk score, which is recommended by the European Society of Cardiology for screening of cardiovascular risk.
“We used the Copenhagen risk score, which is based on data from two large epidemiological studies in the Copenhagen area 16 and is recommended by the European Society of Cardiology for screening of cardiovascular risk 29 .”
Quote in the paperNot a substantial claim0 of 2 sources checked- Rests on an assumption: The Copenhagen risk score is a valid measure of 10-year cardiovascular disease risk in patients with schizophrenia spectrum disorders and abdominal obesity.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLife expectancy in patients with schizophrenia is reduced by 20 years for men and 15 years for women compared to the general population.
“Life expectancy in patients with schizophrenia is reduced by 20 years for men and 15 years for women compared to the general population.”
- Also stated in: § Abstract · plain
“The gap in life expectancy between patients with schizophrenia and the general population -twenty years shorter for men and fifteen years shorter for women 1,2 -is a major challenge to public health.”
Quote in the paperNot a substantial claim0 of 2 sources checked- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThe sample size was estimated to recruit 150 participants per group, total 450, with 90% power and alpha level 0.0167.
“Allowing a power of 90%, we estimated to recruit 150 participants to each intervention group, a total of 450 participants.”
- Also stated in: § Statistical analysis · plain
“we reduced our alpha level to 0.05/3 5 0.0167.”
Quote in the paperNot a substantial claim- Also stated in: § Statistical analysis · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataRetention proportion was 86.0% for the sample as a whole.
“Retention proportion was 86.0% for the sample as a whole.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataDropouts did not differ from completers regarding baseline metabolic or psychometric characteristics or pattern of medication, except for a smaller proportion of the former receiving antidepressant treatment (30.0% vs. 46.0%).
“The dropouts did not differ from completers regarding baseline metabolic or psychometric characteristics or pattern of medication, except for a smaller proportion of the former receiving antidepressant treatment (30.0% vs. 46.0%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data365 participants (85.3%) provided information enabling a calculation of the primary outcome at follow-up.
“365 participants (85.3%) provided information enabling a calculation of the primary outcome at follow-up.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRandomization was centralized and carried out by the Copenhagen Trial Unit using a computerized sequence with alternating block sizes (9, 12 and 15) unknown to the investigators.
“The randomization was centralized and carried out by the Copenhagen Trial Unit using a computerized sequence with alternating block sizes (9, 12 and 15) unknown to the investigators.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe primary outcome analysis was an intention-to-treat one.
“The primary outcome analysis was an intention-to-treat one.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Study design and conductown dataSensitivity analyses of the primary outcome using complete cases, removing outliers, and per-protocol analyses did not change the results.
“The sensitivity analyses of the primary outcome using complete cases, or removing outliers, did not change the results.”
- Also stated in: § RESULTS · plain
“Equally, the per-protocol analysis removing the three participants with no contact at all to the coach did not change the results.”
Quote in the paperNot a substantial claim- Also stated in: § RESULTS · plain
May combine two claims.
PremisecitationSeveral clinical trials have reported an effect of lifestyle modification in this population, indicating that weight reduction and smoking cessation are possible.
“Several clinical trials [12][13][14] have reported an effect of lifestyle modification in this population, indicating that weight reduction and smoking cessation are possible.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12][13][14]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenOutcome assessors, statisticians and all investigators involved in the trial were blinded to patient allocation, but patients and the health professionals providing the interventions were not.
“Outcome assessors, statisticians and all investigators involved in the trial were blinded to patient allocation, but patients and the health professionals providing the interventions were not.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationSeveral factors contribute to the early and frequent development of cardiovascular disease in this population, including genetic vulnerability, metabolic adverse effects of antipsychotics, insufficient treatment of somatic comorbidity, and unhealthy lifestyle.
“Several factors contribute to the early and frequent development of cardiovascular disease in this population, including genetic vulnerability 5 , metabolic adverse effects of antipsychotics 6,7 , insufficient treatment of somatic comorbidity 8 , and unhealthy lifestyle 9 .”
Quote in the paperSubstantial claim0 of 4 sources checkedMay combine two claims.
Study design and conductown dataBaseline characteristics were mostly balanced between groups, but the treatment as usual group had a higher proportion of participants living in supported housings (16.9% vs. 8.7%) and a smaller proportion having diabetes (9.5% vs. 18.6%) compared with the CHANGE group.
“There were no differences between the intervention groups, apart from a higher proportion of participants living in supported housings (16.9% vs. 8.7%) and a smaller proportion having diabetes (9.5% vs. 18.6%) in the treatment as usual group compared with the CHANGE group.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMultiple imputation was used to handle missing data.
“Multiple imputation was used to handle missing data.”
Quote in the paperNot a substantial claim- Rests on an assumption: Missing data were missing at random.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe intervention was developed to be sustainable, using low-budget possibilities in the neighbourhood.
“Ninth, the intervention was developed to be sustainable, using low-budget possibilities in the neighbourhood.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe trial had independent funding.
“First, the design had central randomization; blinded outcome assessments, data management and data analysis; and independent funding.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe authors planned their sample size to avoid substantial type II errors.
“Second, we planned our sample size to avoid substantial type II errors.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThe methods used to intervene reflect the chosen outcome variables.
“The methods used to intervene reflect the chosen outcome variables.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWeight reduction is the most used outcome in trials of behavioural interventions, and the evidence is reported to be favourable, although long-term trials are missing.
“Weight reduction is the most used outcome [46][47][48][49][50][51][52][53][54][55] and the evidence is reported to be favourable 17 , although long-term trials are missing 18 .”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17]
Not checked in the free run.
- cites [18] source
Not checked in the free run.
May combine two claims.
PremisecitationTrials exploring the effect of behavioural interventions frequently use dyslipidaemia, haemoglobin A1c and blood pressure as secondary outcomes, and the evidence is currently low or inadequate.
“Trials exploring the effect of behavioural interventions frequently use dyslipidaemia 46,47,49,52 , haemoglobin A1c 46,56 and blood pressure 46,49,52,56,57 as secondary outcomes, and the evidence is currently low or inadequate 17 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17]
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe authors' results are not in line with previous trials regarding weight reduction and cardiorespiratory fitness, which might be explained by the clinical characteristics of their sample and the type of intervention.
“Thus, our results are not in line with previous trials regarding weight reduction and cardiorespiratory fitness, which might be explained by the clinical characteristics of our sample and the type of intervention.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTrials evaluating the effect of behavioural interventions in reducing metabolic risk factors have shown mixed results.
“Trials evaluating the effect of behavioural interventions in reducing metabolic risk factors have shown mixed results 17 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll contacts with patients were registered.
“Eighth, all contacts with patients were registered.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe authors cannot exclude that selecting a subgroup with more severe somatic comorbidities might have changed their results in favour of care coordination or CHANGE intervention.
“Also, we cannot exclude that selecting a subgroup with more severe somatic comorbidities might have changed our results in favour of care coordination or CHANGE intervention.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenSelf-reporting might be subject to recall problems and social desirability bias.
“As self-reporting might be subject to both recall problems (introducing random errors and thus increasing the risk of type II errors) and social desirability bias (leading to systematic errors)”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFew studies have evaluated the effect of lifestyle interventions on cardiorespiratory fitness in patients with schizophrenia, but they reported promising findings.
“For our key secondary outcome, cardiorespiratory fitness, few studies have evaluated the effect of lifestyle interventions in patients with schizophrenia, but they reported promising findings [43][44][45] .”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningThe sample might differ from previous trials because the authors aimed to optimize external validity by having few exclusion criteria, being assertive in recruitment, and offering an intervention without mandatory elements, to avoid exclusion of the severely ill and volunteer bias.
“Our sample might differ from previous trials, as we aimed to optimize the external validity by having as few exclusion criteria as possible, being assertive in the process of recruitment, and offering an intervention without mandatory elements, in order to avoid exclusion of the severely ill (many trials exclude patients with somatic comorbidity, substance abuse or suicidal ideation) and volunteer”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe authors used a manual-based, well-described and evidence-based theoretical framework.
“Third, we used a manual-based, well-described and evidence-based theoretical framework.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe clinical characteristics of the sample recruited reflect the inclusion and exclusion criteria.
“The clinical characteristics of the sample we recruited reflect our inclusion and exclusion criteria.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningBy comparing lifestyle coaching with care coordination, the authors were able to differentiate between the effect of lifestyle changes and that of sufficient monitoring and treatment of somatic comorbidities.
“Seventh, by comparing lifestyle coaching with care coordination, we were able to differentiate between the effect of lifestyle changes and that of sufficient monitoring and treatment of somatic comorbidities.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe design had central randomization.
“First, the design had central randomization; blinded outcome assessments, data management and data analysis; and independent funding.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe authors had a multifaceted method, allowing staff to work on all known risk factors.
“Fifth, we had a multifaceted method, allowing the staff to work on all the known risk factors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe authors implemented a high-intensity intervention, offering an assertive approach with at least weekly personal contact.
“Fourth, we implemented a high-intensity intervention, offering an assertive approach with at least weekly personal contact.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningThe low prevalence of baseline risk factors might be the result of a successful mandatory examination of blood lipids in the Danish Schizophrenia database, encouraging clinicians to treat risk factors.
“This might be the result of a successful mandatory examination of blood lipids in the Danish Schizophrenia database, encouraging all clinicians across the three intervention groups to treat risk factors.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe composite outcome measure integrated the results even though they might be heterogeneous.
“Sixth, our composite outcome measure integrated the results even though they might be heterogeneous.”
Quote in the paperNot a substantial claim- Rests on an assumption: Currently there is no gold standard for surrogate outcomes in trials aiming to improve cardiovascular health.
- Rests on an assumption: The ideal outcome measures for trials aiming to reduce mortality from cardiovascular disease are hard ones like death.
- Rests on an assumption: Waiting for survival analyses is too time consuming and expensive for most studies.
- Rests on an assumption: Constructing a risk score without non-modifiable risk factors would not yield an accurate estimate of risk.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningMore direct measurements like actigraphs would have been preferable, but they were not considered in this study due to logistic reasons.
“more direct measurements like actigraphs would have been preferable, but they were not considered in this study due to logistic reasons.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Missing data were missing at random.
“Multiple imputation was used to handle missing data.”
“The imputations were based on a linear regression model with 100 imputations and 20 iterations.”
The paper relies on this without support.
The Copenhagen risk score is a valid measure of 10-year cardiovascular disease risk in patients with schizophrenia spectrum disorders and abdominal obesity.
“We used the Copenhagen risk score, which is based on data from two large epidemiological studies in the Copenhagen area 16 and is recommended by the European Society of Cardiology for screening of cardiovascular risk 29 .”
The authors state this as an assumption.
No prior trial has evaluated the effect of lifestyle interventions on a composite score estimating cardiovascular disease risk in patients with schizophrenia spectrum disorders.
“CHANGE is the first trial, to our knowledge, to evaluate the effect of lifestyle interventions on a composite score estimating the risk of cardiovascular disease in patients with For dichotomous outcomes, a mean difference in risk ratios was calculated using the risk ratio in the TAU group as reference schizophrenic spectrum disorders.”
The paper relies on this without support.
A majority of earlier trials have focused on single risk behaviours, such as diet, smoking or physical inactivity.
“However, a majority of earlier trials have focused on single risk behaviours, such as diet or smoking or physical inactivity.”
The paper relies on this without support.
The general population, and even more, a vulnerable population like this one, is facing major barriers to making healthy choices and powerful pressures to select the unhealthy.
“The general population, and even more, a vulnerable population like this one, is facing major barriers to making healthy choices and powerful pressures to select the unhealthy.”
The paper relies on this without support.
Currently there is no gold standard for surrogate outcomes in trials aiming to improve cardiovascular health.
“Currently there is no gold standard for surrogate outcomes in trials aiming to improve cardiovascular health”
The paper relies on this without support.
The ideal outcome measures for trials aiming to reduce mortality from cardiovascular disease are hard ones like death.
“The ideal outcome measures for trials aiming to reduce mortality from cardiovascular disease are obviously hard ones like death.”
The paper relies on this without support.
Waiting for survival analyses is too time consuming and expensive for most studies.
“However, waiting for survival analyses is too time consuming and expensive for most studies”
The paper relies on this without support.
Constructing a risk score without non-modifiable risk factors would not yield an accurate estimate of risk.
“as constructing a risk score without non-modifiable risk factors would not yield an accurate estimate of risk.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
People with severe mental illness experience a range of barriers to engaging in physical activity and exercise, such as high levels of perceived stress, somatic comorbidities, low mood, and a lack of self-confidence and of social support.
“However, people with severe mental illness experience a range of barriers to engaging in physical activity and exercise, such as high levels of perceived stress, somatic comorbidities, low mood, and a lack of self-confidence and of social support 7-11 .”
From Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis (2017) · cites this paper as [11]
The paper’s introductory discussion (page unavailable) recognizes barriers to lifestyle modification among people with severe mental illness, naming cognitive impairment, anxiety, and substance abuse. It does not identify the claimed list—high perceived stress, somatic comorbidities, low mood, low self-confidence, and lack of social support—as barriers specifically to physical activity or exercise. Its measurement of perceived stress does not establish stress as such a barrier. (LLM, conf=0.82)
Experimental — accuracy not yet measuredThe magnitude of weight reduction is similar to the magnitude of weight lost from lifestyle interventions and by adding topiramate or metformin to current antipsychotic medication.
“On the other hand, the magnitude is similar to the magnitude of weight lost from lifestyle interventions (79, 80) and by adding topiramate or metformin to current antipsychotic medication, all being recommended in clinical guidelines (81).”
From Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis (2021) · cites this paper as [80]
The Discussion (page unavailable) says prior behavioural-intervention trials generally reported favourable weight-reduction results. But the CHANGE trial’s Results (page unavailable) found no significant difference in weight between its lifestyle-coaching and comparison groups, and the paper provides no basis for the claimed similarity in magnitude. The topiramate/metformin clause is attached to a different citation, not this source. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807 · see citing works
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · see citing works
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,706 · see citing works
Scale for Assessment of Positive Symptoms (SAPS) 1984
Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423 · see citing works
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251 · see citing works
Self-rated health: a predictor of mortality among the elderly.
Mossey, J. M., & Shapiro, E. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.8.800 · Cited by 2,145 · see citing works
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115 · see citing works
Stein, L. I. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780170034003 · Cited by 1,902 · see citing works
Scale for the Assessment of Negative Symptoms
Andreasen, N. C. (1982) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,878 · see citing works
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573 · see citing works
(1992) · PubMed · Cited by 1,429 · see citing works
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · see citing works
Self-citationCorrell, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820 · see citing works
Lawrence, D., Hancock, K. J., & Kisely, S. (2013) · BMJ · doi:10.1136/bmj.f2539 · Cited by 819 · see citing works
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · see citing works
Self-citationHippocampal Plasticity in Response to Exercise in Schizophrenia
Pajonk, F.-G., Wobrock, T., Gruber, O., Scherk, H., Berner, D., Kaizl, I., Kierer, A., Müller, S., Oest, M., Meyer, T., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.193 · Cited by 592 · see citing works
A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
Daumit, G. L., Dickerson, F. B., Wang, N.-Y., Dalcin, A., Jerome, G. J., Anderson, C. A. M., Young, D. R., Frick, K. D., Yu, A., Gennusa, J. V., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214530 · Cited by 523 · see citing works
Andreassen, O. A., Djurovic, S., Thompson, W. K., Schork, A. J., Kendler, K. S., O’Donovan, M. C., Rujescu, D., Werge, T., van de Bunt, M., Morris, A. P., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.001 · Cited by 506 · see citing works
Diet, smoking and cardiovascular risk in people with schizophrenia
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.6.534 · Cited by 494 · see citing works
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490 · see citing works
Generalizability studies of the Global Assessment of Functioning–Split version
Pedersen, G., Hagtvet, K. A., & Karterud, S. (2006) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.03.008 · Cited by 446 · see citing works
Jørgensen, T., Borch‐Johnsen, K., Thomsen, T. F., Ibsen, H., Glümer, C., & Pisinger, C. H. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000096541.30533.82 · Cited by 416 · see citing works
Self-citationDiet, smoking and cardiovascular risk in people with schizophrenia
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · The British Journal of Psychiatry · doi:10.1192/03-162 · Cited by 392 · see citing works
Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., & Coons, S. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000182493.57090.c1 · Cited by 383 · see citing works
Druss, B. G., Zhao, L., von Esenwein, S. A., Bona, J. R., Fricks, L., Jenkins-Tucker, S., Sterling, E., DiClemente, R., & Lorig, K. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.01.026 · Cited by 363 · see citing works
Miller, W. R., & Rollnick, S. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.01.005 · Cited by 262 · see citing works
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial
Scheewe, T. W., Backx, F. J. G., Takken, T., Jörg, F., van Strater, A. C. P., Kroes, A. G., Kahn, R. S., & Cahn, W. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12029 · Cited by 246 · see citing works
Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., Rosenheck, R., Davis, S. M., Hsiao, J. K., Stroup, T. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.006 · Cited by 223 · see citing works
Björkman, T., & Svensson, B. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480500213733 · Cited by 216 · see citing works
McKibbin, C., Patterson, T., Norman, G., Patrick, K., Jin, H., Roesch, S. C., Mudaliar, S., Barrio, C., O'Hanlon, K. M., Griver, K., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.010 · Cited by 216 · see citing works
Green, C., Yarborough, B. J. H., Leo, M., Yarborough, M. T., Stumbo, S. P., Janoff, S., Perrin, N., Nichols, G., & Stevens, V. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020173 · Cited by 209 · see citing works
Kimhy, D., Vakhrusheva, J., Bartels, M. N., Armstrong, H. F., Ballon, J. S., Khan, S., Chang, R. W., Hansen, M. C., Ayanruoh, L., Lister, A., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv022 · Cited by 207 · see citing works
Toft, U., Kristoffersen, L., Lau, C. J., Borch‐Johnsen, K., & Jørgensen, T. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602503 · Cited by 202 · see citing works
Osborn, D. P. J., Hardoon, S., Omar, R. Z., Holt, R. I. G., King, M., Larsen, J., Marston, L., Morris, R. W., Nazareth, I., Walters, K., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2133 · Cited by 200 · see citing works
The Effects of an Educational Intervention on Antipsychotic‐Induced Weight Gain
Littrell, K. H., Hilligoss, N. M., Kirshner, C. D., Petty, R. G., & Johnson, C. G. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.00237.x · Cited by 190 · see citing works
Bartels, S. J., Pratt, S. I., Aschbrenner, K. A., Barré, L. K., Jue, K., Wolfe, R. S., Xie, H., McHugo, G. J., Santos, M. M., Williams, G. E., et al. (2013) · Psychiatric Services · doi:10.1176/appi.ps.003622012 · Cited by 188 · see citing works
Brar, J. S., Ganguli, R., Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R. A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0208 · Cited by 178 · see citing works
Bartels, S., Pratt, S., Aschbrenner, K., Barre, L., Naslund, J., Wolfe, R. S., Xie, H.-Y., McHugo, G., Jimenez, D. E., Jue, K., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14030357 · Cited by 161 · see citing works
McGinty, E. E., Baller, J. B., Azrin, S. T., Juliano‐Bult, D., & Daumit, G. L. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv101 · Cited by 135 · see citing works
Bruins, J., Jörg, F., Bruggeman, R., Slooff, C., Corpeleijn, E., & Pijnenborg, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112276 · Cited by 129 · see citing works
The effect of rate of weight loss on long‐term weight regain in adults with overweight and obesity
Vink, R. G., Roumans, N. J. T., Arkenbosch, L. A. J., Mariman, E. C. M., & van Baak, M. A. (2016) · Obesity · doi:10.1002/oby.21346 · Cited by 128 · see citing works
Thomsen, T. F., Davidsen, M., Ibsen, H., Jorgensen, T., Jensen, G., & Borch-Johnsen, K. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800508 · Cited by 127 · see citing works
Wu, M.-K., Wang, C., Bai, Y., Huang, C., & Lee, S. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.4.544 · Cited by 123 · see citing works
Construct validity of a revised Physical Activity Scale and testing by cognitive interviewing
Bjerregaard, L. G., Grøenvold, M., Jørgensen, T., & Aadahl, M. (2010) · Scandinavian Journal of Public Health · doi:10.1177/1403494810380099 · Cited by 108 · see citing works
Diagnosis and clinical measurement in psychiatry : a reference manual for SCAN
Wing, J. K., Sartorius, N., & Üstün, T. B. (2008) · Cited by 103 · see citing works
Correll, C. U., Joffe, B. I., Rosen, L. M., Sullivan, T. B., & Joffe, R. T. (2015) · World Psychiatry · doi:10.1002/wps.20187 · Cited by 102 · see citing works
Laursen, T. M., & Nordentoft, M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.027 · Cited by 93 · see citing works
Self-citationMethapatara, W., & Srisurapanont, M. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02225.x · Cited by 84 · see citing works
Attux, C. R. D. F., Martini, L. C., Elkis, H., Tamai, S., Freirias, A., Camargo, M. D. G. M., Mateus, M. D., Mari, J. D. J., Reis, A. F., & Bressan, R. A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-60 · Cited by 75 · see citing works
Forsberg, K. A., Björkman, T., Sandman, P. O., & Sandlund, M. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801985179 · Cited by 71 · see citing works
Álvarez‐Jiménez, M., Martínez‐García, O., Pérez‐Iglesias, R., Ramírez, M. L., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.10.012 · Cited by 67 · see citing works
Wu, M.-H., Lee, C., Hsu, S. C., Chang, C., & Chen, C. Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s81482 · Cited by 62 · see citing works
Lovell, K., Wearden, A. J., Bradshaw, T., Tomenson, B., Pedley, R., Davies, L. M., Husain, N., Woodham, A., Escott, D., Swarbrick, C., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08503 · Cited by 56 · see citing works
Changing the Endpoints for Determining Effective Obesity Management
Ross, R., Blair, S., de Lannoy, L., Després, J.-P., & Lavie, C. J. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.10.002 · Cited by 55 · see citing works
Cordes, J., Thünker, J., Regenbrecht, G., Zielasek, J., Correll, C. U., Schmidt-Kraepelin, C., Lange‐Asschenfeldt, C., Agelink, M. W., Kahl, K. G., Gäebel, W., et al. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.592546 · Cited by 35 · see citing works
Speyer, H., Nørgaard, H. C. B., Hjorthøj, C., Madsen, T. A., Drivsholm, S., Pisinger, C., Gluud, C., Mors, O., Krogh, J., & Nordentoft, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0465-2 · Cited by 20 · see citing works
Self-citationTexier, L. L., Durand, J., Lavault, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093894 · Cited by 8 · see citing works
Poor predictive ability of the risk chart SCORE in a Danish population.
Saidj, M., Jørgensen, T., Prescott, E., & Borglykke, A. (2013) · PubMed · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- World Health Organization, 2008, Waist circumference and waist‐hip ratio: report of a WHO expert consultation
- 10.1111/acps.12029 · DOI · Paper page
Cited by
Sorted by citations
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729 · see citing works
Vancampfort, D., Firth, J., Schuch, F. B., Rosenbaum, S., Mugisha, J., Hallgren, M., Probst, M., Ward, P. B., Gaughran, F., De Hert, M., et al. (2017) · World Psychiatry · doi:10.1002/wps.20458 · Cited by 957 · see citing works
Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., Druss, B., Dudek, K., Freeman, M., Fujii, C., et al. (2017) · World Psychiatry · doi:10.1002/wps.20384 · Cited by 865 · see citing works
Self-citationSolmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438 · see citing works
Cardiovascular disease in patients with severe mental illness
Nielsen, R. E., Banner, J., & Jensen, S. E. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00463-7 · Cited by 389 · see citing works
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324 · see citing works
Erlangsen, A., Andersen, P. K., Toender, A., Laursen, T. M., Nordentoft, M., & Canudas-Romo, V. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30429-7 · Cited by 170 · see citing works
Self-citationAssociation between antipsychotic medication use and diabetes
Holt, R. I. G. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1220-8 · Cited by 162 · see citing works
Svensson, C. K., Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Koyuncu, K., Schjerning, O., Nielsen, J., Ekstrøm, C. T., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12982 · Cited by 66 · see citing works
Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis
Speyer, H., Westergaard, C., Albert, N., Karlsen, M., Stürup, A. E., Nordentoft, M., & Krogh, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.577919 · Cited by 44 · see citing works
Self-citationHealth Coaching Strategies for Weight Loss: A Systematic Review and Meta-Analysis
Sieczkowska, S. M., de Lima, A. P., Swinton, P. A., Dolan, E., Roschel, H., & Gualano, B. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa159 · Cited by 29 · see citing works
Lambert, M., Ruppelt, F., Siem, A.-K., Rohenkohl, A. C., Kraft, V., Luedecke, D., Sengutta, M., Schröter, R., Daubmann, A., Correll, C. U., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.036 · Cited by 29 · see citing works
Ringen, P. A., Falk, R. S., Antonsen, B., Faerden, A., Mamen, A., Rognli, E. B., Solberg, D. K., Martinsen, E. W., & Andreassen, O. A. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1832-6 · Cited by 17 · see citing works
- Authors
- Speyer, H., Christian Brix Nørgaard, H., Birk, M., Karlsen, M., Storch Jakobsen, A., Pedersen, K., Hjorthøj, C., Pisinger, C., Gluud, C., Mors, O., Krogh, J., & Nordentoft, M.
- Affiliations
- University of Copenhagen (DK)
- Psychosis Research Unit Aarhus University Hospital Risskov Denmark
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Mental Health Centre Copenhagen Copenhagen University Hospital Copenhagen Denmark
- Aarhus University (DK)
- Glostrup Hospital (DK)
- ORCID
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2016-06
- Volume
- 15
- Issue
- 2
- Pages
- 155-165
- ISSN
- 1723-8617 (ISSN-L)
- 2051-5545
- PMC
- PMC4911772
- OpenAlex
- W2471447259
- Cited by
- 153
- References
- 59
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 9 · 2023: 11 · 2022: 18 · 2021: 14 · 2020: 19 · 2019: 27 · 2018: 18 · 2017: 13 · 2016: 2
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- World Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Scopus (Elsevier) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Mental Health Services of the Capital Region of Denmark
- Tryg Foundation
- Lundbeck Foundation
- Daehnfeldts Foundation
- Danish Ministry of Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- schizophrenia spectrum disorders, abdominal obesity, cardiovascular risk, lifestyle coaching, care coordination, cardiovascular risk profile, physical activity, cardiorespiratory fitness, smoking, diet, weight, usual care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review